ABSCI CORP (ABSI)       3.36  -0.05 (-1.47%)

3.36  -0.05 (-1.47%)

US00091E1091 - Common Stock - After market: 3.29 -0.07 (-2.08%)

ABSCI CORP3.36

NASDAQ:ABSI (2/7/2023, 7:22:04 PM)-0.05 (-1.47%)

After market: 3.29 -0.07 (-2.08%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-09 2022-11-09/bmo Earnings (Next) N/A N/A
Ins Owners 7.57% Inst Owners 47.66%
Market Cap 310.45M Shares 92.39M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 73.85
IPO 07-22 2021-07-22

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ABSI Daily chart

Company Profile

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. The company is headquartered in Vancouver Washington, Washington and currently employs 216 full-time employees. The company went IPO on 2021-07-22. The firm has developed an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The company uses synthetic biology technologies and deep learning artificial intelligence (AI) to predict, identify, design, construct, screen, select and scale production of biologic drug candidates, and learn from the data it generates. The firm has drug candidates in approximately nine active programs, eight of the active programs are focused on developing production cell lines for drug candidates that the Company's partners are developing. The company has one discovery program, focused on lead optimization with Astellas. The Company’s active programs include Bispecific monoclonal antibodies (mAb), Bispecific T-cell engager, Cytokine, Fab, Multivalent Fc-fusion, Plasma protein and mAb.

Company Info

ABSCI CORP

18105 Se Mill Plain Blvd

Vancouver Washington WASHINGTON

P: 13609491041.0

CEO: Sean McClain

Employees: 216

Website: https://www.absci.com/

ABSI News

News Imagea month ago - Absci CorporationAbsci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AINews Imagea month ago - Absci CorporationAbsci to Participate in the 41st Annual J.P. Morgan Healthcare ConferenceNews Imagea month ago - Absci CorporationAbsci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

VANCOUVER, Wash. and NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced...

News Imagea month ago - Absci CorporationAbsci to Participate in the 41st Annual J.P. Morgan Healthcare ConferenceNews Imagea month ago - Absci CorporationAbsci to Participate in the 41st Annual J.P. Morgan Healthcare Conference

VANCOUVER, Wash. and NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced...

News Image3 months ago - Absci CorporationAbsci to Participate in the Berenberg Discover AI Seminar

ABSI Twits

Here you can normally see the latest stock twits on ABSI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example